Dear Colleagues,

New antibiotics must become a profitable venture for industry if we are to get the new products that we need. However, if we continue to allow sales volumes to directly determine company profits, we should expect continued overuse of these valuable resources and the shorter duration of efficacy that comes with it.

Incentives for stimulating the R&D of new antibiotics are a hot topic right now. Many incentive designs are being put on the table. Some detangle the perverse incentive to maximize sales volumes but others do not. This Special Issue will consider the different ways in which we can remove or hedge against this perverse incentive, update readers on the few pilot programmes that are being put in place to this end, and consider the influence of the COVID-19 pandemic.

This Special Issue discusses the progress that has been made in this area over the past few years, including from the pilot schemes that have been launched, and in light of the COVID-19 pandemic. Crucially, it also considers the political level to assess how change can be best achieved and where movement is needed next, considering the implications of geographic scope.

Dr. Chantal M. Morel
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Antibiotics
• R&D incentives
• sustainable antibiotic use
• antibiotic prescribing
• drug marketing